# Dyne Therapeutics, Inc.: Form 8-K, filed May 2, 2024

- Company: [Dyne Therapeutics, Inc.](/companies/dyn.md) (CIK 1818794)
- Form: 8-K
- Filed: 2024-05-02
- Accepted by EDGAR: May 2, 2024, 20:15 ET
- Period: 2024-05-02
- Accession: 0000950170-24-052142
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1818794/000095017024052142/dyn-20240502.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818794/000095017024052142/

## Items reported

- Item 2.02: Results of operations

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818794/000095017024052142/dyn-20240502.htm

Filed May 2, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-052142. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.